Search

everythinglearnresearchcommunity

for

Search:↓

No current system perfectly classifies male-pattern hair loss, indicating a need for a new system for better diagnosis and treatment.

Women with PCOS have more emotional and body image issues than healthy women.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Both drugs lower DHT levels, with GI198745 being more effective.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

43.1% of rabbits in Mosul City had mange, with Sarcoptes scabiei var. cuniculi being the most common.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Different monkey species in a lab showed varying levels of hair loss due to factors like type, sex, age, season, and living conditions.

The document concludes that hair transplant methods are often selected for provider convenience over patient benefit, highlighting the need for less invasive techniques and careful physician involvement for better results.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

Wool follicles are complex, involving interactions between different cell types and structures.

Ephrins slow down skin and hair follicle cell growth.

Both tissue expansion and serial excision are effective for scar revision in the head and neck area.

Hair restoration, especially at the hairline and frontal hair volume, can improve facial balance and attractiveness, with follicular unit transplantation being a successful method.

Juvéderm Ultra Plus is safe and effective for treating severe nasolabial folds in Chinese subjects.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

A woman had temporary hair loss due to stress from a spinal cord injury.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.